Table 2.
Cellular Origin and Size of EVs Extracted From Human Valves
Aortic Stenosis | Aortic Regurgitation | P Value | |
---|---|---|---|
Leukocytes, CD11a+ | 5.9 ± 1.5 (22) | 4.5 ± 2 (8) | 0.61 |
Platelets, GPIb+ | 1.3 ± 0.50∗∗∗ (22) | 0.18 ± 0.18 (8) | <0.001 |
Erythrocytes, CD235a+ | 1.6 ± 0.57∗∗∗ (22) | 0.18 ± 0.18 (8) | <0.001 |
ECs, CD31+ | 2.4 ± 0.48 (22) | 2.7 ± 0.87 (8) | 0.73 |
Activated ECs, CD105+ | 25.5 ± 3.5 (22) | 26.5 ± 3.1 (8) | 0.08 |
Size, nm | 145.2 ± 3.3 (8) | 149.3 ± 3.2 (7) | 0.82 |
Prothrombinase activity, nmol/L/mg of tissue | 182.3 ± 12.5∗ (65) | 122 ± 16 (13) | 0.03 |
Values are mean ± SEM (n). Extracellular vesicles (EVs) cell origin was determined after capture onto specific antibodies and quantification by prothrombinase assay. Data are of n = 22 (aortic stenosis), n = 8 (aortic regurgitation) for immunocapture experiments, n = 8 (aortic stenosis), n = 7 (aortic regurgitation) for EVs sizing experiments, and n = 65 (aortic stenosis), n = 13 (aortic regurgitation) for prothrombinase activity. The between-group values were compared using Student’s unpaired t-test. ∗<0.05; ∗∗∗<0.001.
ECs = endothelial cells.